Effect of Intrapartum Antibiotic Exposure Time on Neonatal Sepsis: A Prospective Cohort Study
- PMID: 40768031
- DOI: 10.1007/s13312-025-00133-2
Effect of Intrapartum Antibiotic Exposure Time on Neonatal Sepsis: A Prospective Cohort Study
Abstract
Objective: To examine the association between the duration of intrapartum antibiotic exposure (IAE) and the risk of culture-negative early-onset neonatal sepsis (EONS) and any late-onset neonatal sepsis (LONS) in the first week.
Methods: Preterm neonates (≤ 34 weeks) were enrolled into: Group A (no IAE; n = 282), Group B (IAE < 24 h; n = 204) and Group C (IAE ≥ 24 h; n = 84). The risk factors for EONS and LONS were noted and all neonates were followed up for culture-negative EONS (primary outcome). Secondary outcomes included culture-positive EONS, culture-negative and culture-positive LONS, and multidrug-resistant sepsis. A univariable followed by multivariable analysis of risk factors to predict culture-negative EONS and LONS was performed. The cut-off (Youden's index) of IAE associated with various outcomes was determined.
Results: From group A through C, gestation and birth weight declined, and the proportion at risk of EONS increased. Culture-negative EONS incidence increased (9.57% vs. 12.74% vs. 36.90%, respectively, Ptrends < 0.001), but its proportion among all EONS did not. Culture-positive LONS incidence declined (Ptrends = 0.038). The proportion of culture-negative LONS among all LONS increased (Ptrends = 0.024). Threshold values of 13.5 h and 4.5 h were associated with culture-negative EONS and culture-positive LONS in the first week, respectively. However, on adjusted analysis, IAE duration had no association with culture-negative EONS or LONS in the first week.
Conclusions: Duration of IAE is not independently associated with increased incidence of culture-negative EONS or any LONS.
Keywords: Antibiotic prophylaxis; Early-onset sepsis; Late-onset sepsis; Neonate.
© 2025. The Author(s), under exclusive licence to Indian Academy of Pediatrics.
Conflict of interest statement
Declarations. Conflict of interest: None. Ethical Approval: The study was conducted according to the Guidelines of the Helsinki Declaration and the National Ethical Guidelines for Biomedical and Health Research Involving Human Participants. Institute Ethics Committee Ref No: INT/IEC/2017/000318 dated Dec 30, 2017. Data Sharing: De-identified data available on reasonable request from corresponding author.
Similar articles
-
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.Cochrane Database Syst Rev. 2011 Jul 6;(7):CD003510. doi: 10.1002/14651858.CD003510.pub3. Cochrane Database Syst Rev. 2011. PMID: 21735394
-
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.Cochrane Database Syst Rev. 2007 Jan 24;(1):CD003510. doi: 10.1002/14651858.CD003510.pub2. Cochrane Database Syst Rev. 2007. Update in: Cochrane Database Syst Rev. 2011 Jul 06;(7):CD003510. doi: 10.1002/14651858.CD003510.pub3. PMID: 17253490 Updated.
-
Risk factors and risk-indicating model for early-onset neonatal sepsis after preterm prelabor rupture of membranes: A historical cohort study.Acta Obstet Gynecol Scand. 2025 Aug;104(8):1475-1486. doi: 10.1111/aogs.15168. Epub 2025 Jun 1. Acta Obstet Gynecol Scand. 2025. PMID: 40452246 Free PMC article.
-
Antibiotic regimens for management of intra-amniotic infection.Cochrane Database Syst Rev. 2014 Dec 19;2014(12):CD010976. doi: 10.1002/14651858.CD010976.pub2. Cochrane Database Syst Rev. 2014. PMID: 25526426 Free PMC article.
-
Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more).Cochrane Database Syst Rev. 2017 Jan 4;1(1):CD005302. doi: 10.1002/14651858.CD005302.pub3. Cochrane Database Syst Rev. 2017. PMID: 28050900 Free PMC article.
References
-
- Prevention of Group B Streptococcal early-onset disease in newborns: ACOG committee opinion, number 797. In: Obstet Gynecol. 2020;135:e51-e72.
-
- Milton R, Gillespie D, Dyer C, et al. Neonatal sepsis and mortality in low-income and middle-income countries from a facility-based birth cohort: an international multisite prospective observational study. Lancet Glob Health. 2022;10: e661–e72.
-
- van Schalkwyk J, Van Eyk N, Infectious Diseases C. Antibiotic prophylaxis in obstetric procedures. J Obstet Gynaecol Can. 2010;32:878-84